Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials

Amber Meulenbeld,Steven Ramondt, Alberto Papi,Neil J Greening,Surya P Bhatt,Nicolas Roche,Bartolome Celli,Jadwiga A Wedzicha,Àlvar Agustí,Ruth Tal-Singer,MeiLan K Han,Wim Janssens,Nicola A Hanania,Parameswaran Nair,Peter Bremner,Konstantinos Porpodis,Yoko Shibata,Stephanie Korn,Ting Yang,Oliver Gordon,Rebecca Saenz,Julie Ng,Dorothy S Cheung,Jacob Devine,Michele A Grimbaldeston,Wenhui Zhang,Xiaoying Yang,Divya Mohan,Claus F Vogelmeier,Christopher E Brightling on behalf of the ALIENTO and ARNASA investigators

Updated trends in the global prevalence and burden of mental disorders, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

GBD 2023 Mental Disorder Collaborators